The number of people with susceptibility test result for rifampicin in Poland
Poland: The number of people with susceptibility test result for rifampicin was 2,415 in 2021. ▼ Falling
Latest (2021)
2,415
Change on year
up 19.7%
World rank
43rd
of 155 countries
All-time high
3,317
in 2017
All-time low
2,017
in 2020
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Poland, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Poland stood at 2,415.
That represents a change of up 19.7% on the previous year and down 27.2% over five years.
Poland ranks 43rd of 155 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Poland, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 3,317 | — |
| 2018 | 3,196 | -3.6% |
| 2019 | 3,173 | -0.7% |
| 2020 | 2,017 | -36.4% |
| 2021 | 2,415 | +19.7% |
Poland compared with similar countries
- Poland's 2,415 is above the median for high income countries, which is 142, 17.0× the median. (61 countries reporting)
- Poland's 2,415 is above the median for Europe & Central Asia, which is 229.5, 10.5× the median. (44 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 3,229 | 3,173 | 3,317 | 3 |
| 2020s | 2,216 | 2,017 | 2,415 | 2 |
Countries ranked near Poland
More health data for Poland
- Un projection of annual infant deaths, annual growth rate -1.23 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.9071 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,693 deaths per 1,000 people (2090)
- Number of infants who die before age 1 80 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -5.59 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0201 units per person (2025)
- Population ages 00-04, male, annual growth rate -5.49 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Poland?
- The number of people with susceptibility test result for rifampicin in Poland was 2,415 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Poland?
- The highest recorded value was 3,317 in 2017.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Poland?
- The lowest recorded value was 2,017 in 2020.
- How does Poland rank for the number of people with susceptibility test result for rifampicin?
- Poland ranks 43rd out of 155 countries with data for 2021.
- Where does this Poland data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).